Last reviewed · How we verify
NCT07350811: APPABU
Retrospective, Observationnal Study to Investigate Procedural Analgesia Delivered to Patients With Lacerations, Abrasions, Burns and Leg Ulcers.
trial in Skin Laceration in 240 participants. Completed in 15 July 2025.
15 January 2025
Quick facts
| Lead sponsor | Versailles Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 240 |
| Start date | 11 June 2024 |
| Primary completion | 15 January 2025 |
| Estimated completion | 15 July 2025 |
| Sites | 1 location across France |
Conditions studied
- Skin Laceration — all drugs for Skin Laceration →
- Skin Abrasion — all drugs for Skin Abrasion →
- Skin Burn — all drugs for Skin Burn →
- Leg Ulcer — all drugs for Leg Ulcer →
Sponsor
Versailles Hospital
Who can join
18 and older, any sex, with Skin Laceration or Skin Abrasion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main part of the study is a retrospective analysis of 200 reports concerning patients with skin wounds and injuries : * 50 consecutive patient reports dealing with skin lacerations * 50 consecutive patient reports dealing with skin abrasions * 50 consecutive patient reports dealing with skin burns * 50 consecutive patient reports dealing with leg ulcers The study comprises a complementary prospective segment, consisting of data collection from patients and from care delivery personnel, threw short interviews, in order to assess the validity of the retrospective recording on reports.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07350811
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Versailles Hospital trials
Trials by the same sponsor.
- NCT07369245 — Techniques for Activating Consciousness (TAC) for Outpatients With Moderate to Severe Alcohol Addiction · NA · not yet recruiting
- NCT07383779 — Targeted Hypothermia Versus Targeted Normothermia After Convulsive Refractory Status Epilepticus · Phase 3 · not yet recruiting
- NCT06835491 — Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac · Phase 3 · recruiting
- NCT07476755 — Cross-cultural Adaptation and Validation of the French Version of the Social Media Disorder Scale for Parents in a Sampl · completed
- NCT06650813 — Adapting the FACETS Program to Sickle Cell Disease · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07350811 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Versailles Hospital
- Last refreshed: 20 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07350811.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing